✦ LIBER ✦

A phase 1 study of prasugrel in patients with sickle cell disease: Effects on biomarkers of platelet activation and coagulation

✍ Scribed by Jakubowski, Joseph A.; Zhou, Chunmei; Jurcevic, Stipo; Winters, Kenneth J.; Lachno, D. Richard; Frelinger, Andrew L.; Gupta, Neehar; Howard, Jo; Payne, Christopher D.; Mant, Timothy G.

Book ID: 121431623
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 555 KB
Volume: 133
Category: Article
ISSN: 0049-3848
DOI: 10.1016/j.thromres.2013.12.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effect of prasugrel on ADP-stimulate

The effect of prasugrel on ADP-stimulated markers of platelet activation in patients with sickle cell disease

✍ Jakubowski, Joseph A.; Zhou, Chunmei; Winters, Kenneth J.; Lachno, D. Richard; H 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 285 KB

A double-blind, randomized, multicenter

A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease

✍ Ted Wun, Denis Soulieres, Andrew L Frelinger… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 361 KB

Effects of pretreatment with clopidogrel

Effects of pretreatment with clopidogrel on platelet and coagulation activation in patients undergoing elective coronary stenting

✍ Ansgar Weltermann; Peter Fritsch; Paul A Kyrle; Verena Schoenauer; Georg Heinze; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Effects of G-CSF on systemic inflammatio

Effects of G-CSF on systemic inflammation, coagulation and platelet activation in patients with acute myocardial infarction

✍ Birgit A. Steppich; Gabriele Demetz; Stefanie Schulz; Jasper von Wedel; Giesela 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 175 KB

Impact of prescribed opioids on biopsych

Impact of prescribed opioids on biopsychosocial-spiritual function in patients with sickle cell disease: a multi-phase, mixed methods study

✍ Alsalman, A.; Li Wong, J.; Posner, B.; Smith, W. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 92 KB

The in-vitro effects of E5555, a proteas

The in-vitro effects of E5555, a protease-activated receptor (PAR)-1 antagonist, on platelet biomarkers in healthy volunteers and patients with coronary artery disease

✍ Serebruany, Victor L.; Kogushi, Motoji; Dastros-Pitei, Daniela; Flather, Marcus; 📂 Article 📅 2009 🏛 Schattauer 🌐 English ⚖ 101 KB